Long-term modulatory effect of Mycobacterium vaccae treatment on histopathologic changes in a murine model of asthma

Annals of Allergy, Asthma and Immunology

Volumn 98, Issue 6, 2007, Pages 573-579

  Yazi, Didem ^a   Akkoc, Tunc ^a   Ozdemir, Cevdet ^a,b   Yesil, Ozlem ^a   Aydogan, Metin ^a   Sancak, Recep ^a   Bahceciler, Nerin N ^a   Barlan, Isil B ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b Seher Yildizi Sokak   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 5; OVALBUMIN; PHYTOHEMAGGLUTININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BAGG ALBINO MOUSE; CELL CULTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; IMMUNIZATION; IMMUNOMODULATION; MOUSE; MYCOBACTERIUM VACCAE; NEBULIZATION; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; SPLEEN CELL; STATISTICAL ANALYSIS; TH1 CELL;

EID: 34250669592     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60738-7     Document Type: Article

References (13)

1. Global Initiative for Asthma. Bethesda, MD: National Heart, Lung and Blood Institute; 1995. National Institutes of Health publication 95-3659.
2. Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989;299:1259-1260.
3. Del Prete G. Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy. Allergy. 1992;47:450-455.
4. Kapsenberg ML, Hilkens CM, Jansen HM, Bos JD, Snijders A, Wierenga EA. Production and modulation of T-cell cytokines in atopic allergy. Int Arch Allergy Immunol. 1996;110:107-113.
5. Shirakawa T, Enomoto T, Shimazu S, et al. The inverse association between tuberculin responses and atopic disorders. Science. 1997;275:77-79.
6. Wang CC, Rook GA. Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae. Immunology. 1998;93:307-313.
7. Erb KJ, Holloway JW, Sobeck A, et al. Infection of mice with Mycobacterium vaccae- Bacillus Calmette Guerin (BCG) suppresses allergen-induced airway eosinophilia. J Exp Med. 1998;187:561-569.
8. Herz U, Gerhold K, Gruber C, et al. BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J Allergy Clin Immunol. 1998;102:867-874.
9. Ozdemir C, Akkoc T, Bahceciler NN, et al. Impact of Mycobacterium vaccae immunization on lung histopathology in a murine model of chronic asthma. Clin Exp Allergy. 2003;33:266-270.
10. Zuany-Amorim C, Sawicka E, Manlius C, et al. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen specific regulatory T cells. Nature Med. 2002;8:625-629.
11. Zuany-Amorim C, Manlius C, Trifilief A, et al. Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation. J Immunol. 2002;169:1492-1499.
12. Blyth DI, Pedrick MS, Savage TJ, Hessel EM, Fattah D. Lung inflammation and epithelial changes in a murine model of atopic asthma. Am J Respir Cell Mol Biol. 1996;14:425-38]
13. Hopfenspirger MT, Parr SK, Hopp RJ, et al. Mycobacterial antigens attenuate late phase response, airway hyperresponsiveness, and bronchoalveolar lavage eosinophilia in a mouse model of bronchial asthma. Int Immunopharmacol. 2001;1:1743-1751.